Publications 2002 [References 98–124]

98. Turnbull FM, McIntyre PB, Achat HM, Wang H, Stapledon R, Gold M, Burgess MA. National study of adverse reactions following BCG vaccination. Clin Infect Dis 2002;34:447-53. [abstract]

99. Leask J, Chapman S. 'The cold hard facts'. Immunisation and vaccine preventable diseases in Australia's newsprint media 1993-1998. Soc Sci Med 2002;54:121-133. [abstract]

100. Horby P. Rendering beef safe. Clin Infect Dis 2002;34:129. [no abstract available]

101. Leask J, Williams A. Risks and benefits of immunisation - the flip side of the coin. In Touch: newsletter of the Public Health Association of Australia Inc. 2002;19(3):3.[no abstract available]

102. Weerasinghe DW, MacIntyre CR, Rubin GL. The epidemiology of cardiac arrest in a Sydney hospital. Resuscitation 2002;53:53-62. [abstract]

103. Leask J. Vaccination and risk communication: summary of a workshop, Arlington Virginia, USA, 5-6 October 2000. J Paediatr Child Health 2002;38:124-128. [abstract]

104. Hull B, Lawrence G, MacIntyre CR, McIntyre P. Immunisation Coverage: Australia 2001. Canberra: Commonwealth Department of Health and Ageing; May, 2002. [full text]

105. McIntyre P, Gidding H, Gilmour R, Lawrence G, Hull B, Horby P, Wang H, Andrews R, Burgess M. Vaccine preventable diseases and vaccination coverage in Australia, 1999-2000. Commun Dis Intell 2002;26 Suppl:1-111.[full text]

106. MacIntyre CR, Ruth D, Ansari MZ. Hospital in the home is cost saving for appropriately selected patients: a comparison with in-hospital care. Int J Qual Health Care 2002;14:285-93. [abstract]

107. Kelly H, Riddell MA, Gidding H, Nolan T, Gilbert GL. A random cluster survey and a convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, Australia. Vaccine 2002;20:3130-6. [abstract]

108. De Silva S, Saykao P, Kelly H, MacIntyre CR, Ryan N, Biggs BA. Chronic Strongyloides stercoralis infection in Laotian immigrants and refugees 7-20 years after resettlement in Australia. Epidemiol Infect 2002;128:439-44. [abstract]

109. Lin M, Roche P, Spencer J, Milton A, Wright P, Witteveen D, Leader R, Merianos A, Bunn C, Gidding H, Kaldor J, Kirk M, Hall R, Della-Porta T. Australia's notifiable disease status, 2000. Annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 2002;26:118-203. [full text]

110. McMaster P, McIntyre P, Gilmour R, Gilbert L, Kakakios A, Mellis C. The emergence of resistant pneumococcal meningitis-implications for empiric therapy. Arch Dis Child 2002;87:207-10. [abstract]

111. Weerasinghe DP, MacIntyre CR, Rubin GL. Seasonality of coronary artery deaths in New South Wales, Australia. Heart 2002;88:30-4. [abstract]

112. Poynten M, Hanlon M, Irwig L, Gilbert GL. Serological diagnosis of pertussis: evaluation of IgA against whole-cell and specific Bordetella pertussis antigens as markers of recent infection. Epidemiol Infect 2002;128:161-7. [abstract]

113. Williams A. Reduction in the hepatitis B related burden of disease - measuring the success of universal immunisation programs. Commun Dis Intell 2002;26:458-60. [full
text]


114. Torvaldsen S, McIntyre PB. Observational methods in epidemiologic assessment of vaccine effectiveness. Commun Dis Intell 2002;26:451-7. [full text]

115. Davies P, Chapman S, Leask J. Antivaccination activists on the world wide web. Arch Dis Child 2002;87:22-5. [abstract]

116. Nolan T, McIntyre P, Roberton D, Descamps D. Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine. Vaccine 2002;21:281-289. [abstract]

117. MacIntyre CR. The value of epidemiology [letter]. Molecular Pathology Online May 2002. [full text]

118. Forrest JM, Turnbull FM, Sholler GF, Hawker RE, Martin FJ, Doran TT, Burgess MA. Gregg's congenital rubella patients 60 years later. Med J Aust 2002;177:664-7. [full text]

119. Horby P. Variant Creutzfeldt-Jakob disease: an unfolding epidemic of misfolded proteins. Journal of Paediatrics & Child Health 2002;38:539-42. [abstract]

120. Andrews R, Whitfield K, Kelly H, McIntyre P, Butler J. Economic analysis of various options for population level funded influenza and pneumococca immunisation programs. Report to the Commonwealth Department of Health and Ageing, December 2002.

121. Torvaldsen S, Hull BP, McIntyre PB. Using the Australian Childhood Immunisation Register to track the transition from whole cell to acellular pertussis vaccines. Commun Dis Intell 2002;26:581-3. [full text]

122. MacIntyre CR, Gay NJ, Gidding H, Hull B, Gilbert GL, McIntyre P. A mathematical model to measure the impact of the Measles Control Campaign on the potential for measles transmission in Australia.Int J Infect Dis 2002;6:277-82. [abstract]

123. McIntyre P, Elliott E, Morris A, Ridley G, Massie J, McEniery J, Knight G. Hospitalised pertussis in infancy. In: Elliott E, Ridley G, Rose D, Morris A, Redmond D, Fowler J, editors. Australian Paediatric Surveillance Unit Ninth Annual Report 2001. Sydney: APSU; 2002. p. 11-4. [no abstract available]

124. Burgess M, Forrest J. Congenital rubella. In: Elliott E, Ridley G, Rose D, Morris A, Redmond D, Fowler J, editors. Australian Paediatric Surveillance Unit Ninth Annual Report 2001. Sydney: APSU; 2002. p.25. [no abstract available]